The U.S. Food and Drug Administration has approved emergency use authorization for a booster shot of the Pfizer-BioNTech vaccine to be given at least six months after completion of the second dose for ...
NEW YORK, N.Y. — Pfizer and BioNTech announced Tuesday that they’ve made a request for the Food and Drug Administration (FDA) to authorize their COVID-19 booster shot for all adults. Specifically, the ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
PHILADELPHIA (WPVI) -- The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five ...
Pfizer-BioNTech asked the U.S. Food and Drug Administration to expand emergency use of its COVID-19 booster dose to include 16 and 17-year-olds, according to a tweet published by the company’s CEO on ...
Americans could soon see a major increase in access to COVID-19 vaccine booster shots. On Friday, the U.S. Food and Drug Administration (FDA) announced its Vaccines and Related Biological Products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results